Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups.

@article{Mignot2001ComplexHA,
  title={Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups.},
  author={Emmanuel Jean-Marie Mignot and L. Lin and William Rogers and Yutaka Honda and Xiaowen Qiu and X. Lin and Michele L. Okun and Hirohiko Hohjoh and Tetsuro Miki and Susan H Hsu and Mary S. Leffell and F. Carl Grumet and Marcelo A. Fernandez-Vina and Makoto Honda and Neil Risch},
  journal={American journal of human genetics},
  year={2001},
  volume={68 3},
  pages={
          686-99
        }
}
Human narcolepsy-cataplexy, a sleep disorder associated with a centrally mediated hypocretin (orexin) deficiency, is tightly associated with HLA-DQB1*0602. Few studies have investigated the influence that additional HLA class II alleles have on susceptibility to this disease. In this work, 1,087 control subjects and 420 narcoleptic subjects with cataplexy, from three ethnic groups, were HLA typed, and the effects of HLA-DRB1, -DQA1, and -DQB1 were analyzed. As reported elsewhere, almost all… 

Tables from this paper

HLA-DQ allele competition in narcolepsy: a comment on Tafti et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.

Imputing allelic variation at the level of HLA-DQA1, it is shown that this locus also has a considerable effect on disease susceptibility and is compatible with previous findings in multi-ethnic group data sets showing that allele competition effects within the DQ1 group determine the amount of DQ0602, and consequently the risk of developing narcolepsy.

HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy.

Polymorphism located in TCRA locus confers susceptibility to essential hypersomnia with HLA-DRB1*1501-DQB1*0602 haplotype

TCRA is a plausible candidate for susceptibility to EHS patients positive for the HLA-DRB1*1501-DQB1*0602 haplotype, whereas no significant association was observed for E HS patients without this haplotype.

Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy

An unexpected protective HLA haplotype is found near HLA-DQA2, which suggests a virtually causal involvement of the HLA region in narcolepsy susceptibility.

New susceptibility variants to narcolepsy identified in HLA class II region.

Complex HLA class II associations contribute to the genetic predisposition to narcolepsy, and the strongest association was with DQB1*06:01, as reported in previous studies.

Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia

This is the first genome-wide association study of HLA-DQB1*06:02 negative EHS, and the identification of these three new susceptibility loci should provide additional insights to the pathophysiological pathway of this condition.

QB 1 * 0301 and DQB 1 * 0601 Modulate arcolepsy Susceptibility in Koreans

As in other populations, DQB1*0602 homozygosity increased risk in cases with cataplexy and/or hypocretin deficiency, but could not be interpreted in the context of Japanese, AfricanAmericans, European, and North American Caucasians.

Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease

Estimating the disease associations of the range of DR-DQ genotypes and their inferred dimers in a large collection of nuclear families provides new evidence for the potential importance of trans-encoded HLA DQ molecules in the determination of HLA-associated risk in T1D.
...

References

SHOWING 1-10 OF 34 REFERENCES

Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy.

It is concluded that HLA DQA1*0102 and DQB1*0602 are the most likely primary candidate susceptibility genes for narcolepsy in the HLA class II region.

HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group.

Results indicate that HLA-DQB1*0602 homozygosity increases susceptibility to narcolepsy but does not appear to influence disease severity.

HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.

The results show that the HLA association is as tight as previously reported (85-95%) when cataplexy is clinically typical or severe, and patients with mild, atypical, or no catAPlexy have a significantly increased DQB1*0602 frequency in comparison with ethnically matched controls.

Linkage of human narcolepsy with HLA association to chromosome 4p13-q21.

It is suggested that chromosome 4p13-q21 contains a second locus for HLA-associated human narcolepsy, and that a non-HLA gene(s) can contribute to the genetic predisposition even inNarcoleptic cases with HLA association.

Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM).

The genetic predisposition to IDDM is suggested to be defined by the combination of DR- associated susceptibility and DQ-associated susceptibility and by the D Q-associated resistance which is a dominant genetic trait.

DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

It is demonstrated that DQB1*0602/DQA1*0102 is the best marker for narcolepsy across all ethnic groups.

Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.

Haplotype analysis on six families showed that B35-DR2 and other rare haplotypes in normal Japanese were associated with narcolepsy, suggesting an incomplete penetrance of hypersomnia.

Genetic and familial aspects of narcolepsy

This approach, together with positional cloning studies in humans and canines, should reveal the cause of narcolepsy and open new therapeutic avenues.

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease.

These findings are the first to identify a major modulating effect of HLA class I alleles on the susceptibility to a human autoimmune disease; a phenomenon that has previously only been observed in animal models.